R. Rosell

Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.

Montse Sánchez‐Céspedes, Steven A. Ahrendt, Steven Piantadosi et al. · PubMed · 2001 · 170 citations

Tumor Biology, Lung Tumors, Oncology +14

Randomized phase II study of cetuximab in combination with cisplatin (C) and vinorelbine (V) vs. CV alone in the first-line treatment of patients (pts) with epidermal growth factor receptor (EGFR)-expressing advanced non-small-cell lung cancer (NSCLC)

R. Rosell, Catherine Daniel, Rodryg Ramlau et al. · Journal of Clinical Oncology · 2004 · 52 citations

Medicine, Pathology, Phase Ii Study +13

O-271 Phase II randomized study of pemetrexed plus carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

Giorgio V. Scagliotti, C. Kortsik, C. Manegold et al. · Lung Cancer · 2003 · 21 citations

Medicine, Metronomic Therapy, Pathology +7

Prevalence and Clinical Outcomes for Patients With ALK Gene Rearrangement in Europe: Preliminary Results from the European Thoracic Oncology Platform Lungscape Project

Fiona Blackhall, Solange Peters, K.M. Kerr et al. · Annals of Oncology · 2012 · 21 citations · Full text

Advanced Lung Disease, Medicine, Alk Gene Rearrangement +10

An update on European randomized studies in non-small cell lung cancer.

Giuseppe Giaccone, C. Manegold, R. Rosell et al. · PubMed · 1998 · 17 citations